Immune Checkpoint Inhibitors
Daniel P. Petrylak, MD, explores immune checkpoint inhibitors for the management of bladder cancer, especially metastatic urothelial carcinoma.
Read More
International Bladder Cancer Update
Presentations from the 6th International Bladder Cancer Update
These lectures were presented during the 6th Annual International Bladder Cancer Update on November 18, 2022, in Scottsdale, Arizona.
Read More
Enhanced Techniques of NMIBC Detection
Dr. Mark D. Tyson, II, MD, MPH, moderates this session by discussing the critical need for precise detection techniques in managing NMIBC.
Read More
Use of Biomarkers in NMIBC: What’s New and What Should We Use?
Dr. Peter C. Black moderated an insightful panel discussion exploring the latest advancements in the use of biomarkers for non-muscle invasive bladder cancer (NMIBC) and their potential integration into clinical practice.
Read More
Biomarker Integration for Advanced Urothelial Carcinoma
Dr. Donna E. Hansel, MD, PhD delves into the critical role of biomarker integration in the management of advanced urothelial carcinoma.
Read More